[1]
Andersson , P. and Karling , P. 2022. Impact of treatment with immunomodulators and tumour necrosis factor antagonists on the incidence of infectious events in patients with inflammatory bowel disease. Upsala Journal of Medical Sciences. 127, 1 (Jan. 2022). DOI:https://doi.org/10.48101/ujms.v127.8167.